MTInov

Research organisation

MTInov

Description

MTInov was created in 2020 from the association of the Cell Therapy and Tissue Bank Unit (UTCT) of the Nancy CHRU and the Bioprocesses and Biomolecules research axis of the Reaction and Process Engineering Laboratory (LRGP) of the CNRS and UL, This platform for studying, optimising and scaling up the production of cell-based biomedicines has expertise in cell culture in stirred bioreactors (monitoring, intensification, modelling, bioreactor design), as well as in the transfer to clinical grade in compliance with good manufacturing practice (GMP).

MTInov

Address

Contact

Eric.olmos@univ-lorraine.fr

Description

MTInov was created in 2020 from the association of the Cell Therapy and Tissue Bank Unit (UTCT) of the Nancy CHRU and the Bioprocesses and Biomolecules research axis of the Reaction and Process Engineering Laboratory (LRGP) of the CNRS and UL, This platform for studying, optimising and scaling up the production of cell-based biomedicines has expertise in cell culture in stirred bioreactors (monitoring, intensification, modelling, bioreactor design), as well as in the transfer to clinical grade in compliance with good manufacturing practice (GMP).

Matchmaking

Connect with MTInov

This entity is yours?

Update information

Position on the value chain

With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.

Bio-resources and biobanking
  • Cells, tissues and humanized xeno-organs
  • Biosamples
  • Viral, phage or bacterial specimen
Identification of biotherapies
  • Target identification
  • Target validation
  • Screening
Drug design
  • Drug assessment
  • Drug engineering
  • In vitro preclinical studies
Clinical validation
  • Clinical trials
  • In vivo preclinical validation
  • Pre-industrial scale production
Production
  • Upstream processes
  • Downstream processes
  • Quality control
Market access
  • CE mark / market authorisation
  • Payment / Reimbursement
  • Care pathways